MNPR
Monopar Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
5.09 / 10Overall Score
NeturalInvestment Rating
5.09 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of MNPR
- Based on a composite score of 5.09/10, we rate MNPR as a Netural. Our analysis breaks down into 2.86/10 for Fundamentals, 3.58/10 for Technicals, and 6.96/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of MNPR?
Is MNPR undervalued or overvalued?
Is money flowing into or out of MNPR?
Trend Analysis of MNPR
- Based on a composite score of 5.09/10, we rate MNPR as a Netural. Our analysis breaks down into 2.86/10 for Fundamentals, 3.58/10 for Technicals, and 6.96/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is MNPR undervalued or overvalued?
Technical Analysis of MNPR?
Is money flowing into or out of MNPR?
